Xenetic Biosciences
XBIO
6 hedge funds and large institutions have $682K invested in Xenetic Biosciences in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 4 → 6 (+2)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
24% less capital invested
Capital invested by funds: $902K → $682K (-$220K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$18.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.88K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $654K | – | – | – |
|
|
PAM
2
Panagora Asset Management
Boston,
Massachusetts
| $14K | +$18.4K | +57 | New |
|
|
RE
3
RBC Europe
London,
United Kingdom
| $4.52K | +$6.14K | +19 | New |
|
4
Morgan Stanley
New York
| $4K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $4K | +$3.88K | +12 | +300% |
|
|
OIA
6
OneDigital Investment Advisors
Overland Park,
Kansas
| $1K | – | – | – |
|
XBIO Hedge Fund Activity: Q3 2017 in Review
6 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q3 2017, worth a combined $682K — down 24% from $902K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new XBIO positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Panagora Asset Management, opening a new position worth an estimated $18.4K.
- 6 institutional investors held Xenetic Biosciences (XBIO) as of Q3 2017, up from 4 in Q2 2017.
- Funds reported $682K of Xenetic Biosciences stock for Q3 2017, down 24% quarter-over-quarter.
- 2 funds opened new Xenetic Biosciences positions in Q3 2017 and 0 closed out, a net change of +2 holders.
- The largest Xenetic Biosciences buyer in Q3 2017 was Panagora Asset Management, an estimated $18.4K added.
Based on aggregated 13F filings for Q3 2017.